Up next

Autoplay

When should one consider tyrosine kinase inhibitor therapy for medullary thyroid cancer? 153

0 Views • 07/10/23
Share
Embed
administrator
administrator
Subscribers
0

Originally presented at the 23rd International Thyroid Cancer Survivors’ Virtual Conference held October 23-25, 2020.
When should one consider tyrosine kinase inhibitor therapy for medullary thyroid cancer? Robert F. Gagel, MD, Endocrinologist, and Mark E. Zafereo, MD, Head and Neck Surgeon.

Show more
0 Comments sort Sort By
Facebook Comments

Up next

Autoplay